Mirati Therapeutics Inc. buy Stifel Nicolaus
Start price
06.10.23
/
50%
€56.84
Target price
06.10.24
€78.43
Performance (%)
-5.00%
End price
07.10.24
-
Summary
This prediction is currently being closed. With a performance of -5.00%, the BUY prediction for Mirati Therapeutics Inc. by Stifel_Nicolaus is down slightly. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.862% | -1.624% | 0.645% |
| iShares Nasdaq 100 | -3.322% | 3.321% | 32.004% |
| iShares Nikkei 225® | -2.299% | 3.437% | 51.012% |
| iShares S&P 500 | -1.313% | 2.435% | 23.006% |
Comments by Stifel_Nicolaus for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Mirati Therapeutics, Inc. (NASDAQ: MRTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $83.00 price target on the stock.
Ratings data for MRTX provided by MarketBeat
In the thread Trading Mirati Therapeutics Inc.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten